Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors

Transfusion

Volumn 46, Issue 3, 2006, Pages 469-475

  Busch, Michael P ^a   Glynn, Simone A ^b   Stramer, Susan L ^b   Orland, Jennie ^b   Murphy, Edward L ^b   Wright, David J ^b   Kleinman, Steven ^b  

^a Blood Centers of the Pacific   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; NUCLEIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; ASIAN; BLOOD ANALYSIS; BLOOD DONOR; BLOOD GROUP; CHI SQUARE TEST; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; ETHNOLOGY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HISPANIC; HUMAN; LABORATORY DIAGNOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; PATIENT INFORMATION; RNA ANALYSIS; SEROCONVERSION; VIREMIA;

ADULT; AGED; ALANINE TRANSAMINASE; BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; VIREMIA;

EID: 33644676862     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00745.x     Document Type: Article

References (29)

1. Orland JR Wright TL Cooper S Acute hepatitis C [review] Hepatology 2002 33 321 7
2. Marcellin P Hepatitis C. the clinical spectrum of the disease [review] J Hepatol 1999 31 Suppl 1 9 16
3. Busch MP Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients Transfus Clin Biol 2001 8 200 6
4. Dodd RY Notari EP4th Stramer SL Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population Transfusion 2002 42 975 9
5. Wang B Schreiber GB Glynn SA et al. Does prevalence of transfusion-transmissible viral infections reflect corresponding incidence in United States blood donors? Transfusion 2005 45 1089 96
6. Stramer SL Glynn SA Kleinman SH et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid amplification testing N Engl J Med 2004 351 760 8
7. Murphy EL Bryzman SM Glynn SA et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS) Hepatology 2000 31 756 62
8. Orton SL Stramer SL Dodd RY Alter MJ Risk factors for HCV infection among blood donors confirmed to be HCV RNA-positive, anti-HCV non-reactive Transfusion 2004 44 275 81
9. Prince AM Pawlotsky JM Soulier A et al. HCV replication kinetics in chimpanzees with self-limited and chronic infections J Viral Hepat 2004 11 236 42
10. Jauncey M Micallef JM Gilmour S et al. Clearance of hepatitis C virus after newly acquired infection in injection drug users J Infect Dis 2004 190 1270 4
11. Cox AL Netski DM Mosbruger T et al. Prospective evaluation of community-acquired acute hepatitis C Clin Infect Dis 2005 40 951 8
12. Zavaglia C Belli LS Alberti AB Ideo G Silini E Both immunogenetic factors and HCV genotype can influence the outcome of chronic HCV infection Am J Gastroenterol 1997 92 725 6
13. Farci P Shimoda A Coiana A et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies Science 2000 288 339 44
14. Sheridan I Pybus OG Holmes EC Klenerman P High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression J Virol 2004 78 3447 54
15. Laskus T Wilkinson J Gallegos-Orozco JF et al. Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion Gastroenterology 2004 127 764 76
16. Mas A Ulloa E Bruguera M et al. Hepatitis C virus population analysis of a single-source nosocomial outbreak reveals an inverse correlation between viral load and quasispecies complexity J General Virol 2004 85 3619 26
17. Ray SC Wang YM Laeyendecker O et al. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy J Virol 1999 73 2938 46
18. Thomas DL Astemborski J Rai RM et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors JAMA 2000 284 450 6
19. Thio CL Thomas DL Goedert JJ et al. Racial differences in HLA class II associations with hepatitis C virus outcomes J Infect Dis 2001 184 16 21
20. Thio CL Gao X Goedert JJ et al. HLA-Cw*04 and hepatitis C virus persistence J Virol 2002 76 4792 7
21. Sugimoto K Stadanlick J Ikeda F et al. Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response Hepatology 2003 37 590 9
22. Grant PR Busch MP Nucleic acid amplification technology methods used in blood donor screening [review] Transfus Med 2002 12 229 42
23. Giachetti C Linnen JM Kolk DP et al. Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA J Clin Microbiol 2002 40 2408 19
24. Rehermann B Nascimbeni MO Immunology of hepatits B virus and hepatitis C virus infection Nature Rev Immunol 2005 5 215 29
25. Cooper S Erickson AL Adams EJ et al. Analysis of a successful immune response against hepatitis C virus Immunity 1999 10 439 49
26. Diepolder HM Gerlach JT Zachoval R Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection J Virol 1997 71 6011 9
27. Strader DB Wright T Thomas DL Seeff LB Diagnosis, management, and treatment of hepatitis C [published erratum appears in Hepatology 2004;40:269] Hepatology 2004 39 1147 71
28. Tobler LH Murphy EL Andrews WW et al. Follow-up study of HCV seropositive blood donors who tested positive or negative for HCV RNA by minipool-NAT screening Transfusion 2005 45 92A abstract SP208
29. Busch MP Page-Shafer KA Acute-Phase hapititis C virus infection: Implications for research, diagnosis, and treatment Clin Infect Dis 2005 40 959 61